Reformulated imatinib eliminates morphine tolerance in lab studies
Tuesday, February 21, 2012 - 10:31
in Health & Medicine
By reformulating the common cancer drug imatinib (Gleevec), researchers have eliminated morphine tolerance in rats an important step toward improving the effectiveness of chronic pain management in patients, according to researchers at The University of Texas MD Anderson Cancer Center.